Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for IDEXX Laboratories, Inc. (IDXX:NASDAQ), powered by AI.
IDEXX Laboratories, Inc. is currently trading at $573.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for IDEXX Laboratories, Inc. on Alpha Lenz.
IDEXX Laboratories, Inc.'s P/E ratio is 43.5.
“IDEXX Laboratories, Inc. trades at a P/E of 43.5 (premium valuation) with strong ROE of 66.2%. Operating margin of 31.6% indicates strong profitability.”
Ask for details →IDEXX Laboratories, Inc. is a global leader in the medical devices sector, specializing in the development, manufacture, and distribution of diagnostic products and services for animal health, water testing, and food safety. The company’s primary focus is on veterinary diagnostics, supplying point-of-care testing systems, advanced laboratory instruments, rapid assay test kits, and software that support companion animal veterinary practices. Its key products also address microbiological water quality monitoring and the detection of diseases in livestock and poultry, enabling critical biosecurity and animal health management. IDEXX Laboratories has established a significant presence in over 175 countries, leveraging both direct distribution and a network of resellers to reach veterinary clinics, farms, laboratories, and public health entities globally. Headquartered in Westbrook, Maine, and employing around 11,000 people, IDEXX is recognized for its commitment to innovation, robust research and development initiatives, and an expansive product suite that positions it as a cornerstone of animal health and environmental diagnostics worldwide.
“IDEXX Laboratories, Inc. trades at a P/E of 43.5 (premium valuation) with strong ROE of 66.2%. Operating margin of 31.6% indicates strong profitability.”
Ask for details →IDEXX Laboratories, Inc. (ticker: IDXX) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 11,000 employees. Market cap is $46.1B.
The current price is $573 with a P/E ratio of 43.5x and P/B of 28.71x.
ROE is 66.20% and operating margin is 31.60%. Annual revenue is $4.3B.